Real-world data highlights palbociclib's effectiveness in treating advanced breast cancer in India, indicating improved therapy access.
In India, where patients with BC often present at advanced stages due to late diagnosis and limited access to targeted therapies, Palbociclib offers a well-tolerated and effective treatment option. Real-world data from Indian patients highlight its role in bridging treatment gaps, making personalized therapy more accessible, and aligning treatment strategies with global standards.
No takes yet. Share an insight, caveat, or question.
Rajappa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: